News

As per the expanded agreement, Restanza’s in-vitro activity against Neisseria gonorrhoeae and other key STI’s is expected to be assessed, to advance Restanza into clinical development in government-sponsored

GeoVax Labs claimed that although the company’s vaccines are currently being studied for HIV prevention, this is the first study using the same products for treatment of persons

Reportedly, Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting

The acquisition of Aton follows a number of recent acquisitions, including Brazil’s Instituto Terapeutico Delta, in March, and the April acquisition of an unnamed Brazilian company and Canada’s

Bioenergy Life Science said that Corvalen M comprises D-Ribose, a simple, 5-carbon monosaccharide, or pentose sugar. D-Ribose helps accelerate the formation of adenosine triphosphate (ATP), the primary energy

Huya said that the agreement with the School of Chinese Materia Medica of BUCM provides it with access to and first review of certain new therapeutic candidates owned

The patent, titled ‘Molecular Property Modeling Using Ranking’, describes methods for using advanced machine-learning technology to design small molecule compounds in silico that meet specific candidate drug profiles.

Kemwell has decided to increase the production capacity by expanding the production area from 16,000 to 31,000 square meters. The expansion not only makes it possible for the

ABI claimed that by taking Maxisal, cancer patients may be able to relieve at least one of the side effects of cancer therapy, dry mouth. Maxisal was first